Skip to Main Content
All Podcasts

Understanding Cancer Metastases

Transcript

Dr. Gary Friedlaender, Understanding Cancer
Metastases February 22, 2009Welcome to Yale Cancer Center Answers with Dr. Ed Chu, I am
Bruce Barber.  Dr. Chu is Deputy Director and Chief of Medical
Oncology at Yale Cancer Center and is an internationally recognized
expert on colorectal cancer.  If you would like to join the
discussion, you can contact Dr. Chu directly.  The address is
canceranswers@yale.edu
and the phone number is 1888-234-4YCC.  This evening Ed is
joined by Dr. Gary Friedlaender.  Dr. Friedlaender is the
Chair and Wayne O. Southwick Professor of Orthopedics at Yale
School of Medicine.Chu
Our topic for this evening's discussion is metastatic cancer,
specifically the spread of cancer to the bone.  Gary, can you
tell us a little bit about metastatic bone cancer? Why is it that
cancer seems to like to head to bone?Friedlaender
I would be delighted.  First of all the difference between a
benign tumor and a malignant tumor is its ability to spread to
other parts of the body. Sometimes it is close, sometimes it is
far, sometimes it is to bone, and sometimes it targets
organs.  I am an orthopedic surgeon and I spent a little extra
time learning about musculoskeletal oncology from a surgical point
of view, and the most common malignant tumor to bone is metastatic,
that is it came from somewhere else, and did not start in the
skeleton.Chu
What are the types of cancers that typically spread to bone?Friedlaender
Virtually any cancer can spread to bone or to the musculoskeletal
system, but some are far more common; prostate, breast, and lung
are among the most common.  There are two others that are
worthy of mention, and those are thyroid and kidney cancers.Chu
That is interesting. I know in my own disease, colorectal cancer,
that for a long time we did not see it spread to the bone, but as
we are now getting better with treatments, interestingly enough, we
are seeing more and more patients present with bone metastasis as
opposed to metastasis to liver and the lung.Friedlaender
I think you are absolutely right.  We have the good fortune of
helping people live longer and in many cases be cured of their
disease, but some of those that live longer will develop metastatic
disease to the skeleton.Chu
Why is it that these various cancers like to home in on the
bone?Friedlaender
I wish I had a succinct answer to that, and if you give me a little
time maybe you, I, and some of our colleagues will have a better
answer the next time around.  But there clearly are tissues in
the body that are more likely to host cancer, host metastatic
disease, and bone is amongst them.  There seems to be two
general reasons, one is mechanical and one is3:16 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3
 biologic.  With mechanical, I am referring to the filter
system.  There is a very interesting process called the
metastatic cascade, how a tumor cell in one place gets to a place
elsewhere in the body. But for a moment just think about that tumor
cell being in the circulation, in the blood supply, and moving
around the body, mechanically it may get filtered out, filtered out
by one of two major organs; the lungs and the liver. Those two
sites are very common for metastatic disease, and it may be purely
a mechanical issue.  The other is biologic, and there appears
to be some tissues or organs that are receptive to spreading and
some that are particularly unreceptive to spreading aside from
their rich blood supply.  Bone has a very rich blood supply,
and I think it is a combination of being another filter and having
so much blood flow, but there are organs like the spleen that have
enormous blood flow, or the heart which has enormous blood
flow.  They are not immune from metastatic disease, but they
are much less common sites of metastatic disease.  So there is
the mechanical filter system and there is the fertile soil
concept.Chu
Are there any underlying risk factors on the patient's part that
could predispose them, place them at higher risk for developing
bone metastasis?Friedlaender
The simple answer is that it is not their fault. I commonly
reassure people that it is not anything they think they did, or did
not do, that caused their cancer in the first place, or caused it
to spread.  The main risk factor for metastatic disease is
having a primary tumor. It is important to think of cancer, if you
will, as having two components, one is where the tumor starts which
we call the primary, the place it originates, and the second phase
of cancer is everywhere else in the body. That is why you and I are
team, we need to treat where cancer starts and we need to predict
and treat where cancer may go.Chu
And I guess that is why we like to think of cancer as a systemic
disease, even though it might be localized to an area initially.
But the problem is, as you said, those cancer cells are pretty
nifty and they find a way to spread throughout the body.Friedlaender
Absolutely.Chu
Are there are any bones in the body, Gary, which may be at higher
risk for those tumor cells to spread?Friedlaender
It really boils down to the size of the bone.  The long bones
of the body are particularly prone to disease, but ribs are a very
common site of metastatic disease. The spine, where the individual
bones are a little smaller perhaps, are also a very common site
because they have a very rich blood supply.6:45 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3Chu
What would be the common symptoms that one should look out for?Friedlaender
The primary symptom is pain.  As tumors grow they sometimes
cause a bump, or a lump, something noticeable, but primarily it is
pain.  Occasionally, one of the early signs of metastatic
disease to the skeleton is a fracture.  The tumor itself
weakens bone by removing normal strong bone making it weaker and it
breaks.Chu
As we age we all experience aches and pains and backaches, so when
should someone who has some of these symptoms begin to think maybe
it is something more serious and seek medical attention?Friedlaender
A very important point, and I have the privilege of talking about
metastatic disease to the skeleton to students on a regular basis,
and I always come to a pause when we talk about lower back
pain.  I have got back pain, actually I have a little bit
right now, and three out of four Americans have significant lower
back pain. Almost all the time this is degenerative, or a strain,
or sprain, totally devoid of the tumor issue, but every once in a
while somebody has multiple myeloma, or somebody has some malignant
process that is involving the skeleton causing lower back pain.
Sorting out the everyday, frustrating, painful, incapacitating
lower back pain that we see frequently, from something dangerous is
very difficult sometimes. It is important that people who have back
pain that feels different, or is longer lasting than usual, or does
not respond to a little bit of rest or anti-inflammatory
medication, seek medical attention.  And then it is a matter
of being questioned carefully, examined reasonably, and following
those symptoms. When they do not behave the way regular back pain
behaves, those individuals need to be evaluated much more
thoroughly.  You cannot, in our healthcare system, or anyone
else's, have an MRI every time you have back pain. I wish it was
that simple, but the judicious use of our intellect and our tools
should help us find back pain caused by tumors relatively early and
then get down to the business of treating them.Chu
So, if the pain does not resolve immediately with rest, or a little
Advil here and there, or Tylenol, who should they see first? Should
they see their general internist, should they go to their
oncologist, should they seek you out, an orthopedist? Who is the
best person to see initially?Friedlaender
I think all of the above are correct answers, but I certainly think
that seeing one's primary care physician initially, the person that
really should know you the best, is in an excellent position to
help guide you through the rest of the system.Chu
If in fact an individual sees their primary care physician, what
would be some of the tests10:36 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3
 that would be done to try to figure out what is going on?Friedlaender
I am a surgeon, so I am perhaps a little bit more bottom line about
it, and there are lots and lots of tests one can do to prove if a
person is healthy or not, but in the end a plain x-ray of the part
that hurts, after a careful history and physical examination, will
answer most of the questions.  We do have some superb tools to
look more critically as the challenges and the mysteries
deepen.Chu
If x-ray or a CAT scan shows something suspicious in one of the
bones, is there ever any role for a biopsy to see what is going
on?Friedlaender
 Absolutely.  One of the highlights of my day in the office is
telling people they do not have anything wrong.  As we use
some of our tests for other purposes, our CAT scans, MRIs, PET
scans, or bone scans, looking for other disorders and diseases, we
stumble upon changes that are sometimes hard to clarify.  At
centers that are used to seeing unusual things, such as ours that
has a team approach that allows us to make good judgments, we do
windup seeing people who have questions on other tests and just by
looking at these tests we can determine they are harmless, but when
they are still in question, a biopsy is a very important tool.
Biopsies can be done in two general ways.  One is with a
needle and Novocain, we have got lots of Novocain, and we have some
superb pathologists that are used to looking at very, very small
pieces of tissue.  Over 90% of the time we can help an
individual know if they have something serious or not.  The
other option is in the operating room, making a small incision and
getting more samples to look at.Chu
People have heard about this term called the bone scan, which is
commonly used to try to figure out for someone who has cancer if it
has spread to the bone, can you tell us what a bone scan is and
what it does?Friedlaender
A bone scan is a very important tool.  It needs to be used for
the right reasons in the right places, but simply put, and I
apologize I am not used to simple answers, or at least short
answers, but a bone scan involves the injection of a
radiopharmaceutical, a compound that has two characteristics. One
is it emits a little bit of radiation so you can see it on a scan,
and the second is it homes in to bone.  It finds bone that is
particularly active. A bone scan is a thermometer, it goes up and
down, but it does not tell you why, it tells you where. So a bone
scan shows positive, if you will, or we sometimes use the word hot,
a hot spot, if
 it's infected, if its broken, sometimes it has a benign tumor or a
malignant tumor, anything that makes the bone irritated or more
active makes the bone scan positive.14:31 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3Chu 
                
 You are listening to Yale Cancer Center Answers. We are here this
evening discussing options and approaches for treating patients
with metastatic bone cancer, and our guest is Dr. Gary Friedlandaer
from Yale Cancer Center.Chu
Welcome back to Yale Cancer Center Answers, this is Dr. Ed Chu and
I am here in the studio this evening with Dr. Gary Friedlandaer,
Chairman of the Department of Orthopedics at the
Yale School of Medicine.  Gary, before the break we were
talking a lot about why bone is so predisposed for developing
metastasis from primary cancers. When you were talking earlier you
had mentioned this metastatic cascade, can you tell us a little bit
more about what that means?Friedlaender
It is a fascinating sequence of events that begins with the fact
that there is a massive tumor cell somewhere growing. Cells have to
break away from the primary tumor and move through tissue, which is
not easy, it involves enzymes that dissolve some of those tissues,
find a blood vessel or a lymphatic, attach to the outside of that
vessel, drill a hole in that vessel, squeeze a hole in to the blood
vessel or lymphatic, swim upstream I guess it would be, and then
create another hole in the vessel and then move out and grow. That
is the metastatic cascade.  It is not a very simple process;
it is not an easy process.  It requires special cells with
special equipment, and those are some of the malignant cells of the
primary tumor.  If you could interrupt any one of those steps,
you could prevent metastatic disease and you would turn cancer into
a chronic disorder instead of a progressive disease.Chu
By understanding that metastatic cascade process, are there ways to
try, as you said, to interrupt the ability of the tumor to spread
specifically to bone?17:38 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3
 Friedlaender     Yes, and there is a lot of
work going on at Yale, and many other institutions, but perhaps the
endpoint has received the most attention.  In order to grow in
bone, you need to make room for yourself and you need to dissolve
bone.  If you do not dissolve away bone, you have no place to
grow, so one of the effective adjuncts to treatment are
antiresorptive agents, the same kinds of drugs were use to treat
osteoporosis, to make it difficult for tumor cells to dissolve
bone.  These antiresorptive drugs are being used regularly and
they do decrease the incidence and severity of metastatic disease
to bone.  They are called bisphosphonates.Chu
And two of the ones that have been widely used are Zometa and
Aredia. What is fascinating, it is amazing what research tells us,
but there is now recent evidence to suggest that these
bisphosphonates have direct effects on the tumors themselves, and
can sort of kill those tumor cells in addition to having effects on
the bone.Friedlaender
That is correct.  Breast cancer comes to mind in particular,
and multiple myeloma is certainly another disease where these drugs
have been used extensively.  Not only the incidence of bone
metastasis goes down, but the incidence of spread to other organs
goes down as well.Chu
Is there ever any role for surgery in patients who develop bone
metastasis?Friedlaender
Yes.  By removing normal bone it makes the bone weaker and
more susceptible to fracture.  It is important sometimes to
recognize that a bone has a high likelihood of breaking, fix it
before it breaks, if you will, and put a pin in it to do something
that will reduce the likelihood of it breaking.  Radiation
therapy is another excellent way for certain metastatic disease to
the bone to be controlled in terms of pain and its progression and
to stop the weakening before it gets to the danger point.Chu
What you are saying is it really takes a team effort of surgeons,
orthopedic surgeons like yourself, radiation oncologists, and
medical oncologists, to work together to try to come up with a game
plan for patients who have metastatic bone involvement.Friedlaender
It is absolutely critical.  I am an optimist, you and our
colleagues have found ways to cure, literally cure, many people of
their malignancies and there is more to come, but those that wind
up with widespread metastatic disease are generally ill in
important ways that require a team approach.  They are anemic
from their chemotherapy, or from the replacement of their marrow
with tumor, they do not breathe as well because they have tumor in
their lungs, they do not clot appropriately, they have more vein
blood clot disease, their nutrition is poor, and their calcium
metabolism is affected.  These patients are sick and they
require21:39 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3
 a team approach in order to make their journey through the
operating room more efficient and effective. The reason we want to
operate on them in those cases is to relieve their pain, and they
are entitled to pain relief.  We want to preserve their
function or improve their function so that they can walk, or so
that their spine disease does not cause loss of nerve functions. We
want to restore some dignity to their lives so they can be more
self-sufficient; that is a team approach to a very individual
problem.Chu
Is there any role for using radioisotopes in terms of treating
patients who have say, widespread disease?Friedlaender
Again the simple answer is yes, and decades ago one of the very
common ways of trying to treat bone cancer was with an isotope
called strontium.  This is a radioactive material that
preferentially goes to bone, and the radiation part of the molecule
destroys the cells around it.  It did not work out well then,
but the concept has come back because it is a very useful approach.
You find a molecule that finds its way to your target, be it the
bone or the tumor or both, and you attach to it something that
either has radiation effects or pharmaceutical effects, drug
effects, which can be delivered locally; it is like the milkman
going to your house.  It is finding the right address and
delivering the right pharmaceutical to help fight the cancer, and
there are many new approaches that are very promising in that
regard, both for treatment and for diagnosis.  The PET scan,
for example, involves these kinds of molecules that find
particularly active groups of cells and help us understand where
the problem is, so we can better deliver our treatments to those
areas.Chu
It is interesting, over the last 5 to 8 years we have been
developing these new novel targeted therapies for colon cancer,
lung cancer, and breast cancer, and it sounds like a similar type
of targeted approach has also been developed for metastatic
disease, metastatic bone disease.Friedlaender
Correct.Chu
Gary, you and your group at Yale School of Medicine have been very
actively involved in research. Can you tell us a little bit about
what is going on at Yale?Friedlaender
Yale, like many of our colleague academic medical centers, is very
interested in cancer.  As you know, we have a new hospital
opening that is going to focus a lot of attention; the Smilow
Cancer Hospital. This is going to help bring together the different
members of the team and increase efficiency and make it more
effective, and that is about to happen shortly.  We have
scientist who are interested in how bone is made and how bone
repairs itself because when you understand what happens normally,
you have a better chance of25:13 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3
 understanding the consequences of what went wrong when it has
cancer in it, and how to help it repair itself. At Yale our primary
focus is understanding bone in general, and the cells that make
bone.  For example, if you are going to remove bone to make
room for yourself as a cancer, there are special groups of cells
that do that called osteoclasts, and we are looking at how
osteoclasts are formed normally, how they are turned on, and how
they are turned off. If we can selectively turn them off, we can
improve bone mass, we can change the course of osteoporosis, and we
can change the course of metastatic disease to bone.  There
are other opportunities as well, in our parlance, to up-regulate or
down-regulate these special cell populations that remove bone or
make bone.Chu
It is interesting because a number of tumor types, breast cancer
and multiple myeloma in particular, seem to have the ability to
up-regulate the number of these osteoclasts that work to breakdown
bones.  Obviously, if you could figure out how to turn that
process off, that might be a very effective way to develop new
therapies.Friedlaender
That is right.  Some of our tools look like hammers and
screwdrivers and others of our tools are molecules. We are learning
how to combine all of these opportunities to the best advantage of
our patients.  We are much more able to remove parts of the
skeleton and replace them with functional parts.  Sometimes
those are donated bones from other generous individuals; sometimes
those are metals and plastics.Chu
One of the things that just dawned on me, Gary, that we did not
touch upon, is general recommendations for medicines that can help
relieve pain that results from metastatic bone involvement. Could
you just quickly tell us a little bit about what is going on in
that field?Friedlaender
I would be glad to. Pain relief is a right. When we can safely
accomplish it, patients deserve to address their pain in any way we
can. As I said, sometimes it is radiation, sometimes it is surgery,
but very often it is medicine.  A lot of pain comes from
inflammation and some of the simple anti-inflammatory agents are
remarkably helpful in dealing with this type of pain and should not
be overlooked; then there are other narcotic medications. 
When used correctly, this group of drugs is appropriate and
important.Chu
Any last minute words of advice to our listeners out there about
metastatic bone disease?Friedlaender
It is a fact of malignant life that many people who have
malignancies will suffer some of these consequences.  There
are increasing opportunities to interrupt the metastatic cascade
and I do think there is a light at the end of that tunnel. Until we
get there, there are teams of people at places like Yale that are
prepared to help individuals successfully deal with their diseases
and disorders in a compassionate and effective manner.29:04 
into mp3 file
http://www.yalecancercenter.org/podcast/Answers_Feb-22-09.mp3Chu 
 On that note, I would like to thank you Gary for joining me this
evening on the show.  You have been listening to Yale Cancer
Center Answers.  Until next time, I am Ed Chu from Yale Cancer
Center wishing you a safe and healthy week.If you have questions or would like to share your comments,
go to yalecancercenter.org where you can also subscribe to our
podcast and find written transcripts of past programs.  I am
Bruce Barber and you are listening to the WNPR Health Forum from
Connecticut Public Radio.